Manchester Central, Manchester, UK
This meeting is now cancelled, we expect the planned programme will now take place at the 2021 meeting
Preliminary Programme
Symposium Title: Novel Insights into Cardiovascular comorbidities
Monday 1st June 2020, 10.45-12.15
Chairs – Andy Sage, Rhian Touyz
Jose Fuster, CNIC Madrid – Clonal hematopoiesis – links to atherosclerotic disease
Ian Bruce, University of Manchester – Rheumatological diseases – a cardiovascular risk factor
Antony Vidal-Puig, University of Cambridge – Obesity and Adipose dysfunction in cardiovascular risk
Rhian Touyz, University of Glasgow – Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Symposium Title: Neuroimmune Modulation of Cardiovascular Function
Monday 1st June 2020, 13.45-15.15
Chairs – Pasquale Maffia, Tomasz Guzik
Peder Olofsson – Neuronal control of inflammation and bioelectronic medicine
Prof Partha Dutta – Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation
Prof Daniela Carnevale – Neuroimmune Control of Cardiac and Vascular Remodelling in Hypertension
Dr Giuseppe D’Agostino – Control of Peripheral Metabolism via Genetic Modulation of Brain Circuits
Symposium Title: A decade of genome-wide association studies
Tuesday 2nd June 2020, 8.30-10.00
Chairs – Manuel Mayr, Sanjay Sinha
Jeanette Erdmann, Luebeck, Germany – What have we learnt for coronary artery disease?
Aroon Hingorani, UCL – Mendelian randomisation – causal analysis and drug development
Gerard Pasterkamp, Utrect, Netherlands – Fine-tuning the definition of the atherosclerotic plaque at risk, the value of bulk and single cell RNA sequencing of human plaques.
Hugh Watkins, Oxford – The impact of common variants on rare/inherited disease phenotypes
